IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 11,277,561 (50%) | — | ₹17,593 Cr |
| NII (HNI) | — | 3,383,269 (15%) | — | ₹5,278 Cr |
| Retail | — | 7,894,294 (35%) | — | ₹12,315 Cr |
| Σ Total | — | 22,555,124 (100%) | — | ₹351,860 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 90 | ₹14,040 |
| Retail (Max) | 13 | 1,170 | ₹182,520 |
| S-HNI (Min) | 14 | 1,260 | ₹196,560 |
| B-HNI (Min) | 67 | 6,030 | ₹940,680 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE and –
- 2. To carry out the sale of 22,555,124 Equity Shares by the Selling Shareholders. –
Company Overview
Incorporated in 2004, Sharda Cropchem Ltd is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. They are also involved in order based procurement and supply of Belts, general, chemicals, dyes and dye intermediates. Over the years the company has primarily, grown organically and its core strength lies in identifying generic molecules, preparing dossiers, seeking registrations, marketing and distributing formulations or generic active ingredients in fungicide, herbicide and insecticide segments.
They have also recently entered into the biocide segment and have acquired several registrations from the existing registration holders, primarily, in Europe. As of August 5, 2014, it had over 180 Good Laboratory Practices certified dossiers and as of July 15, 2014 it owned over 1,040 registrations for formulations and over 155 registrations for generic active ingredients across Europe, NAFTA, Latin America and Rest of the World.